Why cyanosis in chronic bronchitis




















This site complies with the HONcode standard for trustworthy health information: verify here. Common Health Topics. Symptoms of Lung Disorders. Test your knowledge. Mesothelioma is cancer of the membrane that surrounds the chest wall pleura or abdomen. In the United States, which of the following is the only known cause of mesothelioma? More Content. Was This Page Helpful? Yes No. Shortness of Breath. These absorb the oxygen and transfer it into the blood.

When toxins such as smoke are breathed into the lungs, the particles are trapped and cause a localized inflammatory response. Chemicals released during the inflammatory response e. This leads to significant modifications of lung architecture[1], characterized mainly by intrapulmonary air collections and confining parenchyma collapse [1] ; as far as the process proceeds expiratory bronchial obstruction and thoracic cage expansion also occur, with the clinical picture of COPD.

Mainly decreased is the ability to exude carbon dioxide due to ventilation deficit and, in the more serious cases, oxygen uptake is also impaired. The activity of another molecule called alpha 1-antitrypsin normally neutralizes the destructive action of one of these damaging molecules. After a prolonged period, hyperventilation becomes inadequate to maintain high enough oxygen levels in the blood. The body compensates by vasoconstricting appropriate vessels. This leads to pulmonary hypertension, which places increased strain on the right side of the heart, the one that pumps deoxygenated blood to the lungs, and it often fails.

The failure causes the heart muscle to thicken to pump more blood. Eventually, as the heart continues to fail, it becomes larger and blood backs up in the liver. Emphysema occurs in a higher proportion in patients with decreased alpha 1-antitrypsin A1AT levels alpha 1-antitrypsin deficiency , A1AD. In A1AD, inflammatory enzymes such as elastase are able to destroy the alveolar tissue the elastin fibre, for example. The pattern of emphysema in A1AD is described as panacinar involving the entire acinus as opposed to the centrilobular pattern seen with smoking; the former typically affects the lower lungs, and the former affects the upper lungs.

However, smokers with A1AD are in the highest risk category for emphysema. While A1AD provides some insight into the pathogenesis of the disease, hereditary A1AT deficiency only accounts for a small proportion of the disease. Studies for the better part of the past century have focused mainly upon the putative role of leukocyte elastase also neutrophil elastase , a serine protease found in neutrophils, as a primary contributor to the connective tissue damage seen in the disease.

This hypothesis, a result of the observation that neutrophil elastaseis the primary substrate for A1AT, and A1AT is the primary inhibitor of neutrophil elastase, together have been known as the " protease-antiprotease " theory, implicating neutrophils as an important mediator of the disease. However, more recent studies have brought into light the possibility that one of the many other numerous proteases, especially matrix metalloproteases might be equally or more relevant than neutrophil elastase in the development of non-hereditary emphysema.

The better part of the past few decades of research into the pathogenesis of emphysema involved animal experiments where various proteases were instilled into the trachea of various species of animals. These animals developed connective tissue damage, which was taken as support for the protease-antiprotease theory. However, just because these substances can destroy connective tissue in the lung, as anyone would be able to predict, doesn't establish causality. More recent experiments have focused on more technologically advanced approaches, such as ones involving genetic manipulation.

Perhaps the most interesting development with respect to our understanding of the disease involves the production of protease "knock-out" animals, which are genetically deficient in one or more proteases, and the assessment of whether they would be less susceptible to the development of the disease.

Emphysema is commonly associated with bronchitis and chronic bronchitis. Since it is difficult to delineate "pure" cases of emphysema or chronic bronchitis, they are generally grouped together as chronic obstructive pulmonary disease COPD. See above for alpha 1-antitrypsin deficiency. Severe cases of A1AD may also develop cirrhosis of the liver, where the accumulated A1AT leads to a fibrotic reaction. Emphysema is an irreversible degenerative condition.

The most important measure that can be taken to slow the progression of emphysema is for the patient to stop smoking and avoid all exposure to cigarette smoke and lung irritants. Pulmonary rehabilitation can be very helpful to optimize the patient's quality of life and teach the patient how to actively manage his or her care.

Emphysema is also treated by supporting the breathing with anticholinergics, bronchodilators and inhaled or oral steroid medication, and supplemental oxygen as required. The best way to help prevent COPD is not to smoke. Although both affect the lungs, they are different conditions and need different treatments. COPD often develops after age 40; asthma can start at any age, often during childhood. COPD is a long-lasting disease that usually gets worse over time; asthma attacks come and go.

COPD is often caused by smoking or long-term exposure to pollution or chemicals; asthma is caused by a sensitivity to food, pollen or some drugs, or because of a family history of asthma. With the right diagnosis and treatment, most people with COPD can live a normal, active life. As a community-based health center, Hamakua-Kohala Health provides comprehensive primary and preventative healthcare to persons of all ages, regardless of their ability to pay or health insurance status.

Make an appointment today at one of our clinics. Phone: Amazon donates a percentage of your sales to Hamakua-Kohala Health.

Facebook Instagram.



0コメント

  • 1000 / 1000